Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements - summary of Helocyte's expense related to its clinical research arrangements (Detail)

v3.10.0.1
Sponsored Research and Clinical Trial Agreements - summary of Helocyte's expense related to its clinical research arrangements (Detail) - Helocyte Inc [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Payments For Research And Development Expenses $ 113 $ 1,639 $ 317 $ 2,920
COH Triplex Clinical Research and Support [Member]        
Payments For Research And Development Expenses 0 1,300 0 2,335
COH PepVax Clinical Research And Support [Member]        
Payments For Research And Development Expenses 0 327 0 561
COH Pentamer clinical research and support [Member]        
Payments For Research And Development Expenses $ 113 $ 12 $ 317 $ 24